Flashpoint Therapeutics Names Barry Labinger as CEO
29 Jul 2025 //
CONTRACTPHARMA
Flashpoint Therapeutics Names Barry Labinger as CEO
28 Jul 2025 //
BUSINESSWIRE
Flashpoint Therapeutics Announces $50M KAIMRC Partnership
14 Nov 2024 //
PR NEWSWIRE
CancerVax Taps Flashpoint’s Nanotechnology for Universal Cancer Treatment
29 Aug 2024 //
GLOBENEWSWIRE